Citadel Advisors
VANI icon

Citadel Advisors’s Vivani Medical VANI Stock Holding History

Citadel Advisors’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.1K Sell
14,100
-30,700
-69% -$38.4K ﹤0.01% 12720
2025
Q4 		$55.1K Buy
+44,800
New +$64.7K ﹤0.01% 11994
2025
Q1 		– Sell
-15,900
Closed -$18.4K – 15629
2024
Q4 		$18.4K Sell
15,900
-1,300
-8% -$1.65K ﹤0.01% 13231
2024
Q3 		$20.1K Sell
17,200
-18,500
-52% -$23.1K ﹤0.01% 12765
2024
Q2 		$45K Sell
35,700
-28,100
-44% -$48.2K ﹤0.01% 11883
2024
Q1 		$118K Buy
63,800
+56,344
+756% +$83K ﹤0.01% 11127
2023
Q4 		$7.61K Sell
7,456
-2,433
-25% -$2.41K ﹤0.01% 13279
2023
Q3 		$10.1K Sell
9,889
-500
-5% -$550 ﹤0.01% 13090
2023
Q2 		$12.6K Buy
+10,389
New +$12.8K ﹤0.01% 13075
2023
Q1 		– Sell
-11,787
Closed -$10K – 15564
2022
Q4 		$10K Sell
11,787
-12,552
-52% -$20.4K ﹤0.01% 13648
2022
Q3 		$55K Sell
24,339
-2,094
-8% -$9.93K ﹤0.01% 11560
2022
Q2 		$161K Buy
26,433
+10,333
+64% +$55.7K ﹤0.01% 10916
2022
Q1 		$69K Sell
16,100
-1,000
-6% -$4.2K ﹤0.01% 12589
2021
Q4 		$84K Sell
17,100
-7,133
-29% -$52.1K ﹤0.01% 12893
2021
Q3 		$232K Buy
24,233
+12,633
+109% +$142K ﹤0.01% 11654
2021
Q2 		$172K Buy
+11,600
New +$224K ﹤0.01% 12349
2019
Q2 		– Sell
-471
Closed -$9K – 9895
2019
Q1 		$9K Buy
+471
New +$9.17K ﹤0.01% 9156
2017
Q1 		– Sell
-888
Closed -$42K – 8081
2016
Q4 		$42K Sell
888
-337
-28% -$19.2K ﹤0.01% 6907
2016
Q3 		$103K Buy
1,225
+225
+23% +$19.9K ﹤0.01% 6645
2016
Q2 		$86K Sell
1,000
-529
-35% -$55K ﹤0.01% 6250
2016
Q1 		$177K Buy
1,529
+291
+24% +$33.5K ﹤0.01% 5725
2015
Q4 		$175K Buy
1,238
+42
+4% +$6.15K ﹤0.01% 5976
2015
Q3 		$170K Buy
1,196
+471
+65% +$131K ﹤0.01% 6358
2015
Q2 		$237K Buy
725
+529
+270% +$170K ﹤0.01% 6086
2015
Q1 		$60K Buy
+196
New +$54.5K ﹤0.01% 7269

Other funds holding VANI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.03B AUM 16.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors's VANI Position: Q1 2026 in Review

Citadel Advisors sold out of Vivani Medical (VANI) in Q1 2026, closing a stake of 40,409 shares — an estimated $50.5K sold.

Citadel Advisors first reported a position in VANI in Q1 2015 and held it in 19 quarters. The position peaked at $440K in Q2 2021. 43 funds tracked by Wall St. Rank hold VANI as of Q1 2026.

  • Citadel Advisors reported no remaining Vivani Medical position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 40,409 Vivani Medical shares in Q1 2026, an estimated $50.5K.
  • Citadel Advisors first reported a position in Vivani Medical in Q1 2015 and held it in 19 quarters.
  • Citadel Advisors's Vivani Medical position peaked at $440K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.